世界のアミロイドオリゴマー市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Amyloid Oligomer Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3796
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、アミロイドオリゴマーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗体、検出試薬）、用途別市場規模（生物医学研究、AD治療、クイック診断）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・アミロイドオリゴマーの市場動向
・企業の競争状況、市場シェア
・アミロイドオリゴマーの種類別市場規模と予測2016-2027（抗体、検出試薬）
・アミロイドオリゴマーの用途別市場規模と予測2016-2027（生物医学研究、AD治療、クイック診断）
・アミロイドオリゴマーの北米市場規模2016-2027（アメリカ、カナダ）
・アミロイドオリゴマーの欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・アミロイドオリゴマーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・アミロイドオリゴマーの中南米市場規模2016-2027（メキシコ、ブラジル）
・アミロイドオリゴマーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Novus Biologicals、Merck、Boppard、Abcam、Rockland、GenScript、Cell Signaling Technology、Seebio、Roche Diagnostics）
・結論

Market Analysis and Insights: Global Amyloid Oligomer Market
The global Amyloid Oligomer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Amyloid Oligomer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Amyloid Oligomer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Amyloid Oligomer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Amyloid Oligomer market.

Global Amyloid Oligomer Scope and Market Size
Amyloid Oligomer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Amyloid Oligomer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antibody
Detection Reagent

Segment by Application
Biomedical Research
AD Treatment
Quick Diagnosis

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novus Biologicals
Merck
Boppard
Abcam
Rockland
GenScript
Cell Signaling Technology
Seebio
Roche Diagnostics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Amyloid Oligomer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibody
1.2.3 Detection Reagent
1.3 Market by Application
1.3.1 Global Amyloid Oligomer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Biomedical Research
1.3.3 AD Treatment
1.3.4 Quick Diagnosis
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Amyloid Oligomer Market Perspective (2016-2027)
2.2 Amyloid Oligomer Growth Trends by Regions
2.2.1 Amyloid Oligomer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Amyloid Oligomer Historic Market Share by Regions (2016-2021)
2.2.3 Amyloid Oligomer Forecasted Market Size by Regions (2022-2027)
2.3 Amyloid Oligomer Industry Dynamic
2.3.1 Amyloid Oligomer Market Trends
2.3.2 Amyloid Oligomer Market Drivers
2.3.3 Amyloid Oligomer Market Challenges
2.3.4 Amyloid Oligomer Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Amyloid Oligomer Players by Revenue
3.1.1 Global Top Amyloid Oligomer Players by Revenue (2016-2021)
3.1.2 Global Amyloid Oligomer Revenue Market Share by Players (2016-2021)
3.2 Global Amyloid Oligomer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Amyloid Oligomer Revenue
3.4 Global Amyloid Oligomer Market Concentration Ratio
3.4.1 Global Amyloid Oligomer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Amyloid Oligomer Revenue in 2020
3.5 Amyloid Oligomer Key Players Head office and Area Served
3.6 Key Players Amyloid Oligomer Product Solution and Service
3.7 Date of Enter into Amyloid Oligomer Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Amyloid Oligomer Breakdown Data by Type
4.1 Global Amyloid Oligomer Historic Market Size by Type (2016-2021)
4.2 Global Amyloid Oligomer Forecasted Market Size by Type (2022-2027)

5 Amyloid Oligomer Breakdown Data by Application
5.1 Global Amyloid Oligomer Historic Market Size by Application (2016-2021)
5.2 Global Amyloid Oligomer Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Amyloid Oligomer Market Size (2016-2027)
6.2 North America Amyloid Oligomer Market Size by Type
6.2.1 North America Amyloid Oligomer Market Size by Type (2016-2021)
6.2.2 North America Amyloid Oligomer Market Size by Type (2022-2027)
6.2.3 North America Amyloid Oligomer Market Size by Type (2016-2027)
6.3 North America Amyloid Oligomer Market Size by Application
6.3.1 North America Amyloid Oligomer Market Size by Application (2016-2021)
6.3.2 North America Amyloid Oligomer Market Size by Application (2022-2027)
6.3.3 North America Amyloid Oligomer Market Size by Application (2016-2027)
6.4 North America Amyloid Oligomer Market Size by Country
6.4.1 North America Amyloid Oligomer Market Size by Country (2016-2021)
6.4.2 North America Amyloid Oligomer Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Amyloid Oligomer Market Size (2016-2027)
7.2 Europe Amyloid Oligomer Market Size by Type
7.2.1 Europe Amyloid Oligomer Market Size by Type (2016-2021)
7.2.2 Europe Amyloid Oligomer Market Size by Type (2022-2027)
7.2.3 Europe Amyloid Oligomer Market Size by Type (2016-2027)
7.3 Europe Amyloid Oligomer Market Size by Application
7.3.1 Europe Amyloid Oligomer Market Size by Application (2016-2021)
7.3.2 Europe Amyloid Oligomer Market Size by Application (2022-2027)
7.3.3 Europe Amyloid Oligomer Market Size by Application (2016-2027)
7.4 Europe Amyloid Oligomer Market Size by Country
7.4.1 Europe Amyloid Oligomer Market Size by Country (2016-2021)
7.4.2 Europe Amyloid Oligomer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Amyloid Oligomer Market Size (2016-2027)
8.2 Asia-Pacific Amyloid Oligomer Market Size by Type
8.2.1 Asia-Pacific Amyloid Oligomer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Amyloid Oligomer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Amyloid Oligomer Market Size by Type (2016-2027)
8.3 Asia-Pacific Amyloid Oligomer Market Size by Application
8.3.1 Asia-Pacific Amyloid Oligomer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Amyloid Oligomer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Amyloid Oligomer Market Size by Application (2016-2027)
8.4 Asia-Pacific Amyloid Oligomer Market Size by Region
8.4.1 Asia-Pacific Amyloid Oligomer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Amyloid Oligomer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Amyloid Oligomer Market Size (2016-2027)
9.2 Latin America Amyloid Oligomer Market Size by Type
9.2.1 Latin America Amyloid Oligomer Market Size by Type (2016-2021)
9.2.2 Latin America Amyloid Oligomer Market Size by Type (2022-2027)
9.2.3 Latin America Amyloid Oligomer Market Size by Type (2016-2027)
9.3 Latin America Amyloid Oligomer Market Size by Application
9.3.1 Latin America Amyloid Oligomer Market Size by Application (2016-2021)
9.3.2 Latin America Amyloid Oligomer Market Size by Application (2022-2027)
9.3.3 Latin America Amyloid Oligomer Market Size by Application (2016-2027)
9.4 Latin America Amyloid Oligomer Market Size by Country
9.4.1 Latin America Amyloid Oligomer Market Size by Country (2016-2021)
9.4.2 Latin America Amyloid Oligomer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Amyloid Oligomer Market Size (2016-2027)
10.2 Middle East & Africa Amyloid Oligomer Market Size by Type
10.2.1 Middle East & Africa Amyloid Oligomer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Amyloid Oligomer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Amyloid Oligomer Market Size by Type (2016-2027)
10.3 Middle East & Africa Amyloid Oligomer Market Size by Application
10.3.1 Middle East & Africa Amyloid Oligomer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Amyloid Oligomer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Amyloid Oligomer Market Size by Application (2016-2027)
10.4 Middle East & Africa Amyloid Oligomer Market Size by Country
10.4.1 Middle East & Africa Amyloid Oligomer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Amyloid Oligomer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novus Biologicals
11.1.1 Novus Biologicals Company Details
11.1.2 Novus Biologicals Business Overview
11.1.3 Novus Biologicals Amyloid Oligomer Introduction
11.1.4 Novus Biologicals Revenue in Amyloid Oligomer Business (2016-2021)
11.1.5 Novus Biologicals Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Amyloid Oligomer Introduction
11.2.4 Merck Revenue in Amyloid Oligomer Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Boppard
11.3.1 Boppard Company Details
11.3.2 Boppard Business Overview
11.3.3 Boppard Amyloid Oligomer Introduction
11.3.4 Boppard Revenue in Amyloid Oligomer Business (2016-2021)
11.3.5 Boppard Recent Development
11.4 Abcam
11.4.1 Abcam Company Details
11.4.2 Abcam Business Overview
11.4.3 Abcam Amyloid Oligomer Introduction
11.4.4 Abcam Revenue in Amyloid Oligomer Business (2016-2021)
11.4.5 Abcam Recent Development
11.5 Rockland
11.5.1 Rockland Company Details
11.5.2 Rockland Business Overview
11.5.3 Rockland Amyloid Oligomer Introduction
11.5.4 Rockland Revenue in Amyloid Oligomer Business (2016-2021)
11.5.5 Rockland Recent Development
11.6 GenScript
11.6.1 GenScript Company Details
11.6.2 GenScript Business Overview
11.6.3 GenScript Amyloid Oligomer Introduction
11.6.4 GenScript Revenue in Amyloid Oligomer Business (2016-2021)
11.6.5 GenScript Recent Development
11.7 Cell Signaling Technology
11.7.1 Cell Signaling Technology Company Details
11.7.2 Cell Signaling Technology Business Overview
11.7.3 Cell Signaling Technology Amyloid Oligomer Introduction
11.7.4 Cell Signaling Technology Revenue in Amyloid Oligomer Business (2016-2021)
11.7.5 Cell Signaling Technology Recent Development
11.8 Seebio
11.8.1 Seebio Company Details
11.8.2 Seebio Business Overview
11.8.3 Seebio Amyloid Oligomer Introduction
11.8.4 Seebio Revenue in Amyloid Oligomer Business (2016-2021)
11.8.5 Seebio Recent Development
11.9 Roche Diagnostics
11.9.1 Roche Diagnostics Company Details
11.9.2 Roche Diagnostics Business Overview
11.9.3 Roche Diagnostics Amyloid Oligomer Introduction
11.9.4 Roche Diagnostics Revenue in Amyloid Oligomer Business (2016-2021)
11.9.5 Roche Diagnostics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Amyloid Oligomer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibody
Table 3. Key Players of Detection Reagent
Table 4. Global Amyloid Oligomer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Amyloid Oligomer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Amyloid Oligomer Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Amyloid Oligomer Market Share by Regions (2016-2021)
Table 8. Global Amyloid Oligomer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Amyloid Oligomer Market Share by Regions (2022-2027)
Table 10. Amyloid Oligomer Market Trends
Table 11. Amyloid Oligomer Market Drivers
Table 12. Amyloid Oligomer Market Challenges
Table 13. Amyloid Oligomer Market Restraints
Table 14. Global Amyloid Oligomer Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Amyloid Oligomer Market Share by Players (2016-2021)
Table 16. Global Top Amyloid Oligomer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyloid Oligomer as of 2020)
Table 17. Ranking of Global Top Amyloid Oligomer Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Amyloid Oligomer Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Amyloid Oligomer Product Solution and Service
Table 21. Date of Enter into Amyloid Oligomer Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Amyloid Oligomer Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Amyloid Oligomer Revenue Market Share by Type (2016-2021)
Table 25. Global Amyloid Oligomer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Amyloid Oligomer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Amyloid Oligomer Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Amyloid Oligomer Revenue Market Share by Application (2016-2021)
Table 29. Global Amyloid Oligomer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Amyloid Oligomer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Amyloid Oligomer Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Amyloid Oligomer Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Amyloid Oligomer Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Amyloid Oligomer Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Amyloid Oligomer Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Amyloid Oligomer Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Amyloid Oligomer Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Amyloid Oligomer Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Amyloid Oligomer Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Amyloid Oligomer Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Amyloid Oligomer Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Amyloid Oligomer Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Amyloid Oligomer Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Amyloid Oligomer Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Amyloid Oligomer Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Amyloid Oligomer Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Amyloid Oligomer Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Amyloid Oligomer Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Amyloid Oligomer Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Amyloid Oligomer Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Amyloid Oligomer Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Amyloid Oligomer Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Amyloid Oligomer Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Amyloid Oligomer Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Amyloid Oligomer Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Amyloid Oligomer Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Amyloid Oligomer Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Amyloid Oligomer Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Amyloid Oligomer Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Amyloid Oligomer Market Size by Country (2022-2027) & (US$ Million)
Table 61. Novus Biologicals Company Details
Table 62. Novus Biologicals Business Overview
Table 63. Novus Biologicals Amyloid Oligomer Product
Table 64. Novus Biologicals Revenue in Amyloid Oligomer Business (2016-2021) & (US$ Million)
Table 65. Novus Biologicals Recent Development
Table 66. Merck Company Details
Table 67. Merck Business Overview
Table 68. Merck Amyloid Oligomer Product
Table 69. Merck Revenue in Amyloid Oligomer Business (2016-2021) & (US$ Million)
Table 70. Merck Recent Development
Table 71. Boppard Company Details
Table 72. Boppard Business Overview
Table 73. Boppard Amyloid Oligomer Product
Table 74. Boppard Revenue in Amyloid Oligomer Business (2016-2021) & (US$ Million)
Table 75. Boppard Recent Development
Table 76. Abcam Company Details
Table 77. Abcam Business Overview
Table 78. Abcam Amyloid Oligomer Product
Table 79. Abcam Revenue in Amyloid Oligomer Business (2016-2021) & (US$ Million)
Table 80. Abcam Recent Development
Table 81. Rockland Company Details
Table 82. Rockland Business Overview
Table 83. Rockland Amyloid Oligomer Product
Table 84. Rockland Revenue in Amyloid Oligomer Business (2016-2021) & (US$ Million)
Table 85. Rockland Recent Development
Table 86. GenScript Company Details
Table 87. GenScript Business Overview
Table 88. GenScript Amyloid Oligomer Product
Table 89. GenScript Revenue in Amyloid Oligomer Business (2016-2021) & (US$ Million)
Table 90. GenScript Recent Development
Table 91. Cell Signaling Technology Company Details
Table 92. Cell Signaling Technology Business Overview
Table 93. Cell Signaling Technology Amyloid Oligomer Product
Table 94. Cell Signaling Technology Revenue in Amyloid Oligomer Business (2016-2021) & (US$ Million)
Table 95. Cell Signaling Technology Recent Development
Table 96. Seebio Company Details
Table 97. Seebio Business Overview
Table 98. Seebio Revenue in Amyloid Oligomer Business (2016-2021) & (US$ Million)
Table 99. Seebio Recent Development
Table 100. Roche Diagnostics Company Details
Table 101. Roche Diagnostics Business Overview
Table 102. Roche Diagnostics Amyloid Oligomer Product
Table 103. Roche Diagnostics Revenue in Amyloid Oligomer Business (2016-2021) & (US$ Million)
Table 104. Roche Diagnostics Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Amyloid Oligomer Market Share by Type: 2020 VS 2027
Figure 2. Antibody Features
Figure 3. Detection Reagent Features
Figure 4. Global Amyloid Oligomer Market Share by Application: 2020 VS 2027
Figure 5. Biomedical Research Case Studies
Figure 6. AD Treatment Case Studies
Figure 7. Quick Diagnosis Case Studies
Figure 8. Amyloid Oligomer Report Years Considered
Figure 9. Global Amyloid Oligomer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Amyloid Oligomer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Amyloid Oligomer Market Share by Regions: 2020 VS 2027
Figure 12. Global Amyloid Oligomer Market Share by Regions (2022-2027)
Figure 13. Global Amyloid Oligomer Market Share by Players in 2020
Figure 14. Global Top Amyloid Oligomer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyloid Oligomer as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Amyloid Oligomer Revenue in 2020
Figure 16. Global Amyloid Oligomer Revenue Market Share by Type (2016-2021)
Figure 17. Global Amyloid Oligomer Revenue Market Share by Type (2022-2027)
Figure 18. North America Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Amyloid Oligomer Market Share by Type (2016-2027)
Figure 20. North America Amyloid Oligomer Market Share by Application (2016-2027)
Figure 21. North America Amyloid Oligomer Market Share by Country (2016-2027)
Figure 22. United States Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Amyloid Oligomer Market Share by Type (2016-2027)
Figure 26. Europe Amyloid Oligomer Market Share by Application (2016-2027)
Figure 27. Europe Amyloid Oligomer Market Share by Country (2016-2027)
Figure 28. Germany Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Amyloid Oligomer Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Amyloid Oligomer Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Amyloid Oligomer Market Share by Region (2016-2027)
Figure 38. China Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Amyloid Oligomer Market Share by Type (2016-2027)
Figure 46. Latin America Amyloid Oligomer Market Share by Application (2016-2027)
Figure 47. Latin America Amyloid Oligomer Market Share by Country (2016-2027)
Figure 48. Mexico Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Amyloid Oligomer Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Amyloid Oligomer Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Amyloid Oligomer Market Share by Country (2016-2027)
Figure 54. Turkey Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Amyloid Oligomer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Novus Biologicals Revenue Growth Rate in Amyloid Oligomer Business (2016-2021)
Figure 58. Merck Revenue Growth Rate in Amyloid Oligomer Business (2016-2021)
Figure 59. Boppard Revenue Growth Rate in Amyloid Oligomer Business (2016-2021)
Figure 60. Abcam Revenue Growth Rate in Amyloid Oligomer Business (2016-2021)
Figure 61. Rockland Revenue Growth Rate in Amyloid Oligomer Business (2016-2021)
Figure 62. GenScript Revenue Growth Rate in Amyloid Oligomer Business (2016-2021)
Figure 63. Cell Signaling Technology Revenue Growth Rate in Amyloid Oligomer Business (2016-2021)
Figure 64. Seebio Revenue Growth Rate in Amyloid Oligomer Business (2016-2021)
Figure 65. Roche Diagnostics Revenue Growth Rate in Amyloid Oligomer Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界のロミプロスティム市場規模・現状・予測（2021年-2027年）

Global Romiplostim Market Size, Status and Forecast 2021-2027
QFJ1-5998 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、ロミプロスティムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250μg/ 0.5mL、500μg/ 1mL）、用途別市場規模（成人、小児患者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界のラパチニブ市場規模・現状・予測（2021年-2027年）

Global Lapatinib Market Size, Status and Forecast 2021-2027
QFJ1-5828 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、ラパチニブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250mg錠、タイプII）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界のアニデュラファンギン市場規模・現状・予測（2021年-2027年）

Global Anidulafungin Market Size, Status and Forecast 2021-2027
QFJ1-5581 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アニデュラファンギンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（50mg/各バイアル、100mg/各バイアル）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界のレタパムリン市場規模・現状・予測（2021年-2027年）

Global Retapamulin Market Size, Status and Forecast 2021-2027
QFJ1-5992 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、レタパムリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（1％軟膏（15グラムチューブ）、1％軟膏（30グラムチューブ））、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ...

世界のチプラナビル市場規模・現状・予測（2021年-2027年）

Global Tipranavir Market Size, Status and Forecast 2021-2027
QFJ1-6043 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、チプラナビルの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口液剤、カプセル）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界のリスデキサンフェタミン市場規模・現状・予測（2021年-2027年）

Global Lisdexamfetamine Market Size, Status and Forecast 2021-2027
QFJ1-5832 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、リスデキサンフェタミンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、チュアブル錠）、用途別市場規模（成人ADHD、小児ADHD、成人B.E.D.）、主要地域別市場規模（北米、アメリカ、欧州...

世界のデガレリクス市場規模・現状・予測（2021年-2027年）

Global Degarelix Market Size, Status and Forecast 2021-2027
QFJ1-5692 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、デガレリクスの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バイアル/120mg、バイアル/80mg）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のヒストレリン市場規模・現状・予測（2021年-2027年）

Global Histrelin Market Size, Status and Forecast 2021-2027
QFJ1-5781 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、ヒストレリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（サプレリンLA、ヴァンタス）、用途別市場規模（男の子用、女の子用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のパニツムマブ市場規模・現状・予測（2021年-2027年）

Global Panitumumab Market Size, Status and Forecast 2021-2027
QFJ1-5929 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、パニツムマブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（100mg/5ml単回投与バイアル、400mg/20ml単回投与バイアル）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米...

世界のアリスキレン市場規模・現状・予測（2021年-2027年）

Global Aliskiren Market Size, Status and Forecast 2021-2027
QFJ1-5571 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、アリスキレンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（150mg錠、300mg錠）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...

膵島アミロイドポリペプチドのグローバル市場調査 2019年 The global Islet Amyloid Polypeptide market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Islet Amyloid Polypeptide volume and value at global level, regional level and company level. From a global persp…
シリコーンオリゴマーのグローバル市場調査 2019年 The global Silicone Oligomer market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Silicone Oligomer volume and value at global level, regional level and company level. From a global perspective, this rep…
シリコーンオリゴマーのグローバル市場調査 2019年 The global Silicone Oligomer market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Silicone Oligomer volume and value at global level, regional level and company level. From a global perspective, this rep…
世界の食物アレルギー診断治療市場規模・現状・予測（2021年-2027年） A food allergy is a condition that causes your immune system to treat a normally harmless type of food as if was a dangerous virus, bacteria, or other infectious agent. The immune system response to a food allergy ranges from mild rashes to abdominal pain to a life-threatening complication called an…
世界のTCR-T療法試薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global TCR-T Therapy Reagent Market The global TCR-T Therapy Reagent market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report…